Please login to the form below

Not currently logged in
Email:
Password:

Seres

This page shows the latest Seres news and features for those working in and with pharma, biotech and healthcare.

Microbiome specialist Rebiotix chalks up C. diff trial success

Microbiome specialist Rebiotix chalks up C. diff trial success

Seres that is spearheading a push into pharma.

Latest news

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2016 Deal Watch January 2016

    Each target could accrue $80m in milestone payments. Continuing to build on its interests in pharma, Nestlé put in place a $1.9bn headline deal with Seres Therapeutics. ... 32, 000. Seres Therapeutics/ Nestle Health Science. Collaboration. Rights to

  • A patient's eye view of the digital doctor A patient's eye view of the digital doctor

    Somebody who understands this better than most is Michael Seres, an evangelising ePatient passionate about the ability of new technologies and social media to help him, his condition and his

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Turnstone Biologics bolsters leadership team Turnstone Biologics bolsters leadership team

    Otero joins from Seres Therapeutics, where he was vice president of bioprocess development and manufacturing. ... Prior to his role at Seres, Otero served Merck &Co as its director of engineering.

  • Former Merck & Co exec to lead Seres Former Merck & Co exec to lead Seres

    Former Merck &Co exec to lead Seres. Roger Pomerantz was senior VP at pharma giant. ... Seres has appointed Dr Roger Pomerantz, formerly a senior figure at Merck &Co, to lead the company as CEO and chairman.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics